Korean J Dermatol.
2000 Jun;38(6):798-801.
Four cases of Stevens-Johnson Syndrome associated with Methazolamide Treatment
- Affiliations
-
- 1Department of Dermatology, Chonnam University Medical School, Kwangju, Korea.
Abstract
- Methazolamide is a carbonic anhydrase inhibitor commonly used for lowering intraocular pressure in glaucoma and other ophthalmologic diseases. Carbonic anhydrase inhibitors are sulfonamide derivatives that are known to cause many adverse side effects, including dermatologic reactions. Recently, Stevens-Johnson syndrome (SJS) associated with methazolamide treatment has been reported in Japanese and Japanese Americans, and it suggested a relationship between genetic background and methazolamide-induced SJS. We report four cases of SJS induced by methazolamide. Methazolamide should be prescribed with caution in patients of Japanese or Korean descent.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Five Cases of Stevens-Johnson Syndrome May Be Associated with Methazolamide Treatment
- Two Cases of HLA-B59(+) Stevens-Johnson Syndrome (SJS)-Toxic Epidermal Necrolysis (TEN) Associated with Methazolamide Treatment
- Three Cases of Stevens-Johnson Syndrome Associated with Methazolamide Treatment
- Association of HLA Type with Stevens-Johnson Syndrome Induced by Methazolamide Treatment
- A Case of Stevens-Johnson Syndrome Caused by Acetazolamide
